AMBBY (Ambu AS) Beta: 1.6493 (As of Jun. 26, 2026)


AMBBY Ambu AS AMBBY
84 GF Score
Price $9.43
GF Value $19.37
Valuation Significantly Undervalued
View Full Analysis

What is Ambu AS Beta?

Ambu AS AMBBY +10.36% 84 Beta is 1.6493 as of Jun. 26, 2026. GuruFocus rates AMBBY with a GF Score™ of 84/100 and a GF Value™ of $19.37 (Significantly Undervalued).

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2026-06-26), Ambu AS's Beta is 1.6493.


Ambu AS  (OTCPK:AMBBY) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)


Ambu AS Beta Related Terms


Ambu AS Beta Historical Data

* Premium members only.

The historical data trend for Ambu AS's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ambu AS Beta Chart

Ambu AS Annual Data
Trend Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
Beta
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.36 0.71 1.39 1.81 1.64

Ambu AS Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.97 1.65 1.64 1.66 1.88

AMBBY vs ABT, SYK, MDT: Beta Comparison

For the Medical Devices subindustry, Ambu AS's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ambu AS Beta vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Ambu AS's Beta distribution charts can be found below:

* The bar in red indicates where Ambu AS's Beta falls into.


AMBBY
84GF Score
Ambu AS AMBBY
Beta is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ambu AS Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.

Frequently Asked Questions Learn more about Beta →
What does a Beta of 1.6493 mean?
Ambu AS (AMBBY) has a Beta of 1.6493 as of Jun. 26, 2026. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Ambu AS and its competitors.
Is Ambu AS's Beta too high?
Ambu AS's current Beta is 1.6493. Overall, Ambu AS has a GF Score™ of 84/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Ambu AS's Beta compare to ABT and SYK?
Ambu AS's Beta of 1.6493 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beta for a Medical Devices & Instruments company?
A good Beta depends on the Medical Devices & Instruments industry context. However, Beta should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beta mean?
A high Beta can signal that a stock is expensive relative to its fundamentals. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Ambu AS and its competitors. Ambu AS's current Beta is 1.6493. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ambu AS stock overvalued right now?
Based on GuruFocus' analysis, Ambu AS (AMBBY) is currently considered Significantly Undervalued. The stock's GF Value™ is $19.37, compared to a current price of $9.43 — trading 51.3% below its estimated fair value. The current Beta is 1.6493. Ambu AS's overall GF Score™ is 84/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beta calculated?
Beta is calculated from a company's financial statements. For Ambu AS (AMBBY), the current Beta is 1.6493 as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Ambu AS (AMBBY) Overvalued in 2026?

Based on GuruFocus' analysis, Ambu AS stock appears to be undervalued. The current stock price of $9.43 is trading 51.3% below its estimated GF Value™ of $19.37. GuruFocus considers Ambu AS to be Significantly Undervalued.

Key valuation signals for AMBBY:

  • Beta: 1.6493
  • GF Value™: $19.37 vs. price of $9.43 (51.3% below fair value)
  • GF Score™: 84/100

No single metric tells the full story. See the AMBBY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Ambu AS Business Description

Address Baltorpbakken 13, Ballerup, DNK, DK-2750
Ambu AS provides medical technology solutions. The company's business consists of research and development of new solutions, which are then manufactured, marketed, and sold. It operates in two verticals: Endoscopy Solutions and Anesthesia & Patient Monitoring, with the majority of revenue being generated from the Endoscopy Solutions business. Geographical segments include North America, Europe, and the Rest of the World.
84GF Score

Get the complete analysis for AMBBY

Beta is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$9.43
Price
$19.37
GF Value